| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Brughera Marco Maria, Director
Received 20,000 shares by exercise or conversion ($42.2K) · Sold 20,000 shares ($240K) |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | 144 |
| 12 Nov 2026 | 10-Q |
| 02 Nov 2026 |
Form 4: Evans Terry L, Chief Commercial Officer
Received 168 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Sayad Pierre Sargis, Chief Medical Officer
Received 168 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Hackman Jeffrey S., Director
Received 1,159 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Cioffi Christiana Marie, Chief Strategy Officer
Received 156 shares as a grant or award |
| 02 Nov 2026 |
Form 4: Andrade Robert, CHIEF FINANCIAL OFFICER
Received 1,703 shares as a grant or award |
| 19 Oct 2026 | SCHEDULE 13G/A |
| 13 Oct 2026 |
Form 4: Sayad Pierre Sargis, Chief Medical Officer
Received 3,846 shares as a grant or award ($21.3K) |
| 13 Oct 2026 |
Form 4: Hackman Jeffrey S., Director
Received 2,224 shares as a grant or award ($12.3K) |
| 13 Oct 2026 |
Form 4: Evans Terry L, Chief Commercial Officer
Received 2,326 shares as a grant or award ($12.9K) |
| 13 Oct 2026 |
Form 4: Cioffi Christiana Marie, Chief Strategy Officer
Received 3,946 shares as a grant or award ($21.8K) |
| 13 Oct 2026 |
Form 4: Andrade Robert, CHIEF FINANCIAL OFFICER
Received 3,846 shares as a grant or award ($21.3K) |
| 01 Oct 2026 |
Form 4: Sayad Pierre Sargis, Chief Medical Officer
Received 168 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Evans Terry L, Chief Commercial Officer
Received 168 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Hackman Jeffrey S., Director
Received 1,159 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Cioffi Christiana Marie, Chief Strategy Officer
Received 156 shares as a grant or award |
Loading...